Puma Biotechnology Inc (PBYI.N)
July 22 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adeptus Health, Chipotle Mexican Grill and Yadkin Financial, on Friday. HIGHLIGHTS * Chicago Bridge & Iron Co : Baird cuts to neutral * D.R. Horton Inc : BofA Merrill cuts to neutral from buy * Humana Inc : Wolfe Research raises to outperform * Community Bank System Inc : Sandler O'Neill cuts to
* Submits NDA for PB272 (neratinib) to U.S. FDA for extended adjuvant treatment of HER2-positive early stage breast cancer Source text for Eikon: Further company coverage:
* "look forward to obtaining full 5-year dfs data, which we anticipate will be available in 2017"
* Puma biotechnology submits marketing authorization application (MAA) for PB272 (neratinib) as extended adjuvant treatment of her2-positive early stage breast cancer in europe
BRIEF-Paulson & Co ups share stake in Puma Biotechnology Inc by 52.8 pct to 70,300 shares - Sec Filing
* Paulson & Co ups share stake in Puma Biotechnology Inc by 52.8 pct to 70,300 shares - Sec Filing
* Puma biotechnology reports first quarter 2016 financial results
Earnings vs. Estimates
Analyst Research Reports
Provider : ValuEngine, Inc.
Puma Biotechnology Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.
Provider : Pechala's Reports
Provider : GlobalData
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.